Accenture (ACN) Officer Buys 73 Shares at $250.74 鈥� Form 4 Filing

Q: Who filed the Form 4 for Accenture (ACN)?

The reporting person is Manish Sharma ; the Form 4 was signed by attorney-in-fact Danika Haueisen on 08/06/2025 .

Q: What transaction is reported on the Accenture (ACN) Form 4 dated 08/05/2025?

A purchase of 73 Class A ordinary shares of Accenture at $250.74 per share on 08/05/2025 .

Q: How many shares does Manish Sharma beneficially own after the transaction?

The Form 4 reports 1,731 Class A ordinary shares beneficially owned following the transaction (Direct).

Q: Was the purchase made under a company program?

Yes. The filing states the purchase was pursuant to the Accenture Voluntary Equity Investment Program .

[Form 4] Accenture PLC Insider Trading Activity

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Transaction: On 08/05/2025 Manish Sharma, an officer of Accenture plc (title listed as CEO-The Americas), purchased 73 Class A ordinary shares of Accenture (ACN) at $250.74 per share pursuant to the Accenture Voluntary Equity Investment Program.

Holdings and form details: Following the purchase the reporting person beneficially owned 1,731 Class A ordinary shares (Direct). No derivative securities are reported. The Form 4 was signed by attorney-in-fact Danika Haueisen on 08/06/2025.

Insights

TL;DR: Routine small insider purchase reported; no derivatives and direct ownership updated.

The Form 4 documents a single non-derivative acquisition of 73 Class A ordinary shares by Manish Sharma on 08/05/2025 at $250.74 per share under the Accenture Voluntary Equity Investment Program, resulting in 1,731 shares beneficially owned directly. The filing contains no derivatives, dispositions, or additional material disclosures. The purchase appears administrative and executed via the company's program; the filing was executed by an attorney-in-fact on 08/06/2025.

TL;DR: Disclosure is complete for the reported transaction; shows routine equity participation by an officer.

The filing explicitly states the transaction was made pursuant to Accenture's Voluntary Equity Investment Program and identifies the reporter as an officer with the title "CEO-The Americas." The disclosure includes post-transaction beneficial ownership and a manual signature date. There are no indications of amendments, derivative activity, or other governance concerns in this submission.

08/06/2025 - 04:58 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sharma Manish

(Last)

(First)

(Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO

60661

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CEO-The Americas

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A ordinary shares	08/05/2025		A		73⁽¹⁾	A	$250.74	1,731	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Voluntary Equity Investment Program.

Remarks:

	/s/ Danika Haueisen, Attorney-In-Fact for Manish Sharma	08/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

Who filed the Form 4 for Accenture (ACN)?

The reporting person is Manish Sharma; the Form 4 was signed by attorney-in-fact Danika Haueisen on 08/06/2025.

What transaction is reported on the Accenture (ACN) Form 4 dated 08/05/2025?

A purchase of 73 Class A ordinary shares of Accenture at $250.74 per share on 08/05/2025.

How many shares does Manish Sharma beneficially own after the transaction?

The Form 4 reports 1,731 Class A ordinary shares beneficially owned following the transaction (Direct).

Was the purchase made under a company program?

Yes. The filing states the purchase was pursuant to the Accenture Voluntary Equity Investment Program.

Were any derivative securities reported on this Form 4 for ACN?

No. Table II for derivative securities contains no reported entries in this filing.

AG真人官方

[Form 4] Accenture PLC Insider Trading Activity

Insights

FAQ

Who filed the Form 4 for Accenture (ACN)?

What transaction is reported on the Accenture (ACN) Form 4 dated 08/05/2025?

How many shares does Manish Sharma beneficially own after the transaction?

Was the purchase made under a company program?

Were any derivative securities reported on this Form 4 for ACN?

NYSE:ACN

ACN Rankings

ACN Latest News

ACN Latest SEC Filings

ACN Stock Data

AG真人官方

Trending News

[Form 4] Accenture PLC Insider Trading Activity

Insights

Securities Analyst neutral

Corporate Governance Expert neutral

FAQ

Who filed the Form 4 for Accenture (ACN)?

What transaction is reported on the Accenture (ACN) Form 4 dated 08/05/2025?

How many shares does Manish Sharma beneficially own after the transaction?

Was the purchase made under a company program?

Were any derivative securities reported on this Form 4 for ACN?

NYSE:ACN

ACN Rankings

ACN Latest News

ACN Latest SEC Filings

ACN Stock Data